June 2026
The global leukemia inhibitory factor (LIF) market size is estimated to hit around USD 3.13 billion by 2035 increasing from USD 1.34 billion in 2025, with a CAGR of 8.85%.
March 2026
The global factoring services market size was exhibited at USD 5.13 billion in 2025 and is predicted to hit around USD 12.41 billion by 2035, expanding at a CAGR of 10.34%
February 2026
The global plant factory market size is estimated to hit around USD 3.43 billion by 2035 increasing from USD 1.62 billion in 2025, with a CAGR of 7.78%.
January 2026
The global smart factory market size was calculated at USD 170.43 billion in 2025 and is projected to hit around USD 418 billion by 2035 with a CAGR of 9.39%.
December 2025
The acute lymphocytic leukemia therapeutics market size is expected to hit around USD 11.00 billion by 2035 from USD 4.19 billion in 2025 with a CAGR of 10.13%.
August 2025
The global epidermal growth factors (EGFs) market size is estimated to hit around USD 1.72 billion by 2034 increasing from USD 1.19 billion in 2024, with a CAGR of 3.75%.
August 2025
The global fibroblast growth factors (FGFs) market size is estimated to hit around USD 8.03 billion by 2034 increasing from USD 3.54 billion in 2024, with a CAGR of 8.54%.
August 2025
The global hepatocyte growth factors (HGFs) market size was valued at USD 72.76 million in 2024 and is expected to hit around USD 122.65 million by 2034, growing at a CAGR of 5.36%.
August 2025
The global platelet-derived growth factors market size is estimated to hit around USD 3.23 billion by 2034 increasing from USD 1.3 billion in 2024, with a CAGR of 9.54%.
July 2025
The global reverse factoring market size was valued at USD 637.69 billion in 2024 and is expected to hit around USD 1,715.15 billion by 2034 with a CAGR of 10.40%.
July 2025
The global tumor necrosis factor inhibitor drugs market size is projected to hit around USD 51.55 billion by 2034 from USD 42.86 billion in 2024 with a CAGR of 1.86%.
June 2025
The multi-factor authentication market size is projected to cross around USD 83.72 billion by 2034, increasing from USD 16.85 billion in 2024 with a CAGR of 17.39%.